225 related articles for article (PubMed ID: 21036946)
1. Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study.
Meinitzer A; Kielstein JT; Pilz S; Drechsler C; Ritz E; Boehm BO; Winkelmann BR; März W
Clin Chem; 2011 Jan; 57(1):112-21. PubMed ID: 21036946
[TBL] [Abstract][Full Text] [Related]
2. Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study).
Meinitzer A; Seelhorst U; Wellnitz B; Halwachs-Baumann G; Boehm BO; Winkelmann BR; März W
Clin Chem; 2007 Feb; 53(2):273-83. PubMed ID: 17185364
[TBL] [Abstract][Full Text] [Related]
3. Symmetrical dimethylarginine predicts mortality in the general population: observations from the Dallas heart study.
Gore MO; Lüneburg N; Schwedhelm E; Ayers CR; Anderssohn M; Khera A; Atzler D; de Lemos JA; Grant PJ; McGuire DK; Böger RH
Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2682-8. PubMed ID: 24008162
[TBL] [Abstract][Full Text] [Related]
4. Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.
Siegerink B; Maas R; Vossen CY; Schwedhelm E; Koenig W; Böger R; Rothenbacher D; Brenner H; Breitling LP
Clin Res Cardiol; 2013 Mar; 102(3):193-202. PubMed ID: 23073705
[TBL] [Abstract][Full Text] [Related]
5. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
Emrich IE; Zawada AM; Martens-Lobenhoffer J; Fliser D; Wagenpfeil S; Heine GH; Bode-Böger SM
Clin Res Cardiol; 2018 Mar; 107(3):201-213. PubMed ID: 29101459
[TBL] [Abstract][Full Text] [Related]
6. Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria.
Zobel EH; von Scholten BJ; Reinhard H; Persson F; Teerlink T; Hansen TW; Parving HH; Jacobsen PK; Rossing P
Cardiovasc Diabetol; 2017 Jul; 16(1):88. PubMed ID: 28697799
[TBL] [Abstract][Full Text] [Related]
7. Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition.
Wang Z; Tang WH; Cho L; Brennan DM; Hazen SL
Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1383-91. PubMed ID: 19542023
[TBL] [Abstract][Full Text] [Related]
8. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology?
Busch M; Fleck C; Wolf G; Stein G
Amino Acids; 2006 May; 30(3):225-32. PubMed ID: 16680555
[TBL] [Abstract][Full Text] [Related]
9. Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients.
Shafi T; Hostetter TH; Meyer TW; Hwang S; Hai X; Melamed ML; Banerjee T; Coresh J; Powe NR
Am J Kidney Dis; 2017 Jul; 70(1):48-58. PubMed ID: 28089476
[TBL] [Abstract][Full Text] [Related]
10. Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease.
Böger RH; Endres HG; Schwedhelm E; Darius H; Atzler D; Lüneburg N; von Stritzky B; Maas R; Thiem U; Benndorf RA; Diehm C
J Intern Med; 2011 Mar; 269(3):349-61. PubMed ID: 21175900
[TBL] [Abstract][Full Text] [Related]
11. Arginine, dimethylated arginine and homoarginine in relation to cardiovascular risk in patients with moderate chronic kidney disease.
Hov GG; Aasarød KI; Sagen E; Åsberg A
Clin Biochem; 2015 Jul; 48(10-11):646-51. PubMed ID: 25828044
[TBL] [Abstract][Full Text] [Related]
12. Higher serum asymmetric dimethylarginine is related to higher risk of heart failure in the EPIC-Potsdam study.
Wirth J; Atzler D; di Giuseppe R; Cordts K; Menzel J; Böger RH; Boeing H; Weikert C; Schwedhelm E
Amino Acids; 2017 Jan; 49(1):173-182. PubMed ID: 27796501
[TBL] [Abstract][Full Text] [Related]
13. Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Lung; 2017 Dec; 195(6):717-727. PubMed ID: 28852826
[TBL] [Abstract][Full Text] [Related]
14. Association of Uremic Solutes With Cardiovascular Death in Diabetic Kidney Disease.
Sapa H; Gutiérrez OM; Shlipak MG; Katz R; Ix JH; Sarnak MJ; Cushman M; Rhee EP; Kimmel PL; Vasan RS; Schrauben SJ; Feldman HI; Seegmiller JC; Brunengraber H; Hostetter TH; Schelling JR;
Am J Kidney Dis; 2022 Oct; 80(4):502-512.e1. PubMed ID: 35351578
[TBL] [Abstract][Full Text] [Related]
15. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
[TBL] [Abstract][Full Text] [Related]
16. Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia.
Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Kulkarni P; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Respir Res; 2017 Jan; 18(1):25. PubMed ID: 28114935
[TBL] [Abstract][Full Text] [Related]
17. Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study.
Aucella F; Maas R; Vigilante M; Tripepi G; Schwedhelm E; Margaglione M; Gesualdo L; Boeger R; Zoccali C
Atherosclerosis; 2009 Dec; 207(2):541-5. PubMed ID: 19501358
[TBL] [Abstract][Full Text] [Related]
18. High Levels of Methylarginines Were Associated With Increased Mortality in Patients With Severe Sepsis.
Mortensen KM; Itenov TS; Haase N; Müller RB; Ostrowski SR; Johansson PI; Olsen NV; Perner A; Søe-Jensen P; Bestle MH
Shock; 2016 Oct; 46(4):365-72. PubMed ID: 27206279
[TBL] [Abstract][Full Text] [Related]
19. Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival.
Winkler MS; Nierhaus A; Rösler G; Lezius S; Harlandt O; Schwedhelm E; Böger RH; Kluge S
Crit Care; 2018 Sep; 22(1):216. PubMed ID: 30231905
[TBL] [Abstract][Full Text] [Related]
20. Homoarginine/ADMA ratio and homoarginine/SDMA ratio as independent predictors of cardiovascular mortality and cardiovascular events in lower extremity arterial disease.
Jud P; Hafner F; Verheyen N; Meinitzer A; Gary T; Brodmann M; Seinost G; Hackl G
Sci Rep; 2018 Sep; 8(1):14197. PubMed ID: 30242192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
